Does Renal Sympathetic Denervation Impact the Outcome in Sepsis-Induced Shock? An Experimental Porcine Model
Abstract
1. Introduction
2. Materials and Methods
2.1. Animals and Preparation
2.2. Anesthesia and Ventilation
2.3. Experimental Protocol and Surgical Technique
2.4. Autopsy and Histopathological Analysis
2.5. Hemodynamics, Monitoring and Urine Output
2.6. Laboratory Parameters
2.7. Statistical Analysis
3. Results
3.1. Systemic Hemodynamic Measurements
3.2. Inflammatory Biomarkers
3.3. Coagulation System Markers
3.4. Renal Function and Electrolyte Biomarkers
3.5. Hepatic Function Biomarkers
3.6. Analysis of Alterations from Baseline to Septic Shock
3.7. Microscopic Findings and Histopathological Analysis
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| SNS | Sympathetic Nervous System |
| RSD | Renal Sympathetic Denervation |
| SBP | Systolic Blood Pressure |
| DBP | Diastolic Blood Pressure |
| HR | Heart Rate |
| WBC | White Blood Cell Count |
| CRP | C-Reactive Protein |
| PT | Prothrombin Time |
| INR | International Normalized Ratio |
| aPTT | Activated Partial Thromboplastin Time |
| PLT | Platelet Count |
| BUN | Blood Urea Nitrogen |
| CREA | Creatinine |
| AST/SGOT | Aspartate Aminotransferase |
| ALT/SGPT | Alanine Aminotransferase |
| K | Potassium |
| Na | Sodium |
| OR | Odds Ratio |
| ER | Expected Frequency |
| BH | Benjamini–Hochberg |
References
- Calzavacca, P.; Bailey, M.; Velkoska, E.; Burrell, L.M.; Ramchandra, R.; Bellomo, R.; May, C.N. Effects of Renal Denervation on Regional Hemodynamics and Kidney Function in Experimental Hyperdynamic Sepsis. Crit. Care Med. 2014, 42, e401–e409. [Google Scholar] [CrossRef] [PubMed]
- Standl, T.; Annecke, T.; Cascorbi, I.; Heller, A.R.; Sabashnikov, A.; Teske, W. The Nomenclature, Definition and Distinction of Types of Shock. Dtsch. Ärzteblatt Int. 2018, 15, 757–768. [Google Scholar] [CrossRef]
- De Kock, I.; Van Daele, C.; Poelaert, J. Sepsis and Septic Shock: Pathophysiological and Cardiovascular Background as Basis for Therapy. Acta Clin. Belg. 2010, 65, 323–329. [Google Scholar] [CrossRef] [PubMed]
- Aguilar, M.G.; AlHussen, H.A.; Gandhi, P.D.; Kaur, P.; Pothacamuri, M.A.; Talikoti, M.A.H.; Avula, N.; Shekhawat, P.; Silva, A.B.; Kaur, A.; et al. Sepsis-Associated Acute Kidney Injury: Pathophysiology and Treatment Modalities. Cureus 2024, 16, e75992. [Google Scholar] [CrossRef] [PubMed]
- Zarbock, A.; Nadim, M.K.; Pickkers, P.; Gomez, H.; Bell, S.; Joannidis, M.; Kashani, K.; Koyner, J.L.; Pannu, N.; Meersch, M.; et al. Sepsis-associated acute kidney injury: Consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat. Rev. Nephrol. 2023, 19, 401–417. [Google Scholar] [CrossRef] [PubMed]
- Taccone, F.S.; Su, F.; De Deyne, C.; Abdellhai, A.; Pierrakos, C.; He, X.; Donadello, K.; Dewitte, O.; Vincent, J.L.; De Backer, D. Sepsis Is Associated with Altered Cerebral Microcirculation and Tissue Hypoxia in Experimental Peritonitis. Crit. Care Med. 2014, 42, e114–e122. [Google Scholar] [CrossRef] [PubMed]
- Nishihara, M.; Shinohara, K.; Ikeda, S.; Akahoshi, T.; Tsutsui, H. Impact of sympathetic hyperactivity induced by brain microglial activation on organ damage in sepsis with chronic kidney disease. J. Intensiv. Care 2024, 12, 31. [Google Scholar] [CrossRef] [PubMed]
- Tang, F.; Wu, S.; Zou, Z.; Li, X.; Qiao, L. The core role of central nervous system in sepsis-related organ damage. Front. Immunol. 2025, 16, 1694003. [Google Scholar] [CrossRef] [PubMed]
- May, C.N.; Calzavacca, P.; Ishikawa, K.; Langenberg, C.; Wan, L.; Ramchandra, R.; Bellomo, R. Novel targets for sepsis-induced kidney injury: The glomerular arterioles and the sympathetic nervous system. Exp. Physiol. 2012, 97, 1168–1177. [Google Scholar] [CrossRef] [PubMed]
- Symplicity HTN-1 Investigators. Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months. Hypertension 2011, 57, 911–917. [CrossRef] [PubMed]
- Doumas, M.; Faselis, C.; Papademetriou, V. Renal Sympathetic Denervation and Systemic Hypertension. Am. J. Cardiol. 2010, 105, 570–576. [Google Scholar] [CrossRef] [PubMed]
- Drexel, T.; Bertog, S.C.; Vaskelyte, L.; Sievert, H. Renal denervation. Anadolu Kardiyol. Derg. 2014, 14, 186–191. [Google Scholar] [CrossRef] [PubMed]
- Papademetriou, V.; Tsioufis, C.; Doumas, M. Renal Denervation and Symplicity HTN-3: “Dubium Sapientiae Initium” (Doubt Is the Beginning of Wisdom). Circ. Res. 2014, 115, 211–214. [Google Scholar] [PubMed]
- Chen, X.; Meng, J.; Zhou, Q.; Ni, Y.; Zuo, C.; Zhang, Y. Efficacy and Safety of Catheter-Based Renal Denervation for Patients With Hypertension: A Systematic Review and Meta-Analysis. J. Clin. Hypertens. 2025, 27, e70080. [Google Scholar]
- Soleimani, H.; Sattartabar, B.; Parastooei, B.; Eshraghi, R.; Nazari, R.; Najdaghi, S.; Hobaby, S.; Etemadi, A.; Mahalleh, M.; Taheri, M.; et al. Renal Denervation Effects on Blood Pressure in Resistant and Uncontrolled Hypertension: A Meta-Analysis of Sham-Controlled Randomized Clinical Trials. Clin. Cardiol. 2025, 48, e70104. [Google Scholar] [PubMed]
- Kandzari, D.E.; Mahfoud, F.; Townsend, R.R.; Kario, K.; Weber, M.A.; Schmieder, R.E.; Tsioufis, K.; Pocock, S.; Liu, M.; DeBruin, V.; et al. Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results from the SPYRAL HTN-ON MED Trial. Circ. Cardiovasc. Interv. 2025, 18, e015194. [Google Scholar] [CrossRef] [PubMed]
- Stephan, D.; Morisot, E.; Bronner, F.; Prinz, E.; Calcaianu, M.; Cordeanu, E.M. Renal denervation in 2025: Long-term evidence supporting sympathetic modulation as a durable strategy for uncontrolled hypertension. Int. J. Cardiol. Cardiovasc. Risk Prev. 2026, 29, 200587. [Google Scholar] [CrossRef] [PubMed]
- Iliakis, P.; Dimitriadis, K.; Tatakis, F.; Vakka, A.; Sakalidis, A.; Pyrpyris, N.; Fragoulis, C.; Konstantinidis, D.; Aznaouridis, K.; Tsioufis, K. Safety and Efficacy of Renal Denervation for the Treatment of Resistant Hypertension in Patients with Chronic Kidney Disease: A Narrative Review of the Literature. Biomedicines 2025, 13, 1951. [Google Scholar] [CrossRef] [PubMed]
- Azeez, G.A.; Thirunagari, M.; Fatima, N.; Anand, A.; Palvia, A.R.; Kaur, A.; Nassar, S.T. The Efficacy of Renal Denervation in Treating Resistant Hypertension: A Systematic Review. Cureus 2024, 16, e67007. [Google Scholar] [CrossRef] [PubMed]
- Zeijen, V.J.M.; Völz, S.; Zeller, T.; Mahfoud, F.; Kunz, M.; Kuck, K.H.; Andersson, B.; Graf, T.; Sievert, H.; Kahlert, P.; et al. Long-term safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 8-year results from the ACHIEVE study. Clin. Res. Cardiol. 2024. [Google Scholar] [CrossRef] [PubMed]
- Post, E.H.; Su, F.; Hosokawa, K.; Taccone, F.S.; Herpain, A.; Creteur, J.; De Backer, D.; Vincent, J.-L. The effects of acute renal denervation on kidney perfusion and metabolism in experimental septic shock. BMC Nephrol. 2017, 18, 182. [Google Scholar] [CrossRef] [PubMed]
- Wang, W.; Falk, S.A.; Jittikanont, S.; Gengaro, P.E.; Edelstein, C.L.; Schrier, R.W. Protective effect of renal denervation on normotensive endotoxemia-induced acute renal failure in mice. Am. J. Physiol. Renal. Physiol. 2002, 283, F583–F587. [Google Scholar] [CrossRef] [PubMed]
- Böhner, A.M.C.; Jacob, A.M.; Heuser, C.; Stumpf, N.E.; Effland, A.; Abdullah, Z.; Meyer-Schwesiger, C.; von Vietinghoff, S.; Kurts, C. Renal Denervation Exacerbates LPS- and Antibody-induced Acute Kidney Injury, but Protects from Pyelonephritis in Mice. J. Am. Soc. Nephrol. 2021, 32, 2445–2453. [Google Scholar] [CrossRef] [PubMed]
- Zurek-Leffers, F.M.; Lehmann, F.; Brabenec, L.; Kintrup, S.; Hellenthal, K.E.M.; Mersjann, K.; Kneifel, F.; Hessler, M.; Arnemann, P.-H.; Kampmeier, T.-G.; et al. A model of porcine polymicrobial septic shock. Intensiv. Care Med. Exp. 2023, 11, 31. [Google Scholar] [CrossRef]
- Vintrych, P.; Al-Obeidallah, M.; Horák, J.; Chvojka, J.; Valešová, L.; Nalos, L.; Jarkovská, D.; Matějovič, M.; Štengl, M. Modeling sepsis, with a special focus on large animal models of porcine peritonitis and bacteremia. Front Physiol. 2023, 13, 1094199. [Google Scholar] [CrossRef] [PubMed]
- Fish, R.E.; Brown, M.J.; Danneman, P.J.; Karas, A.Z. Anesthesia and Analgesia in Laboratory Animals; Elsevier Science: Amsterdam, The Netherlands, 2011. [Google Scholar]
- Cicero, L.; Fazzotta, S.; Palumbo, V.D.; Cassata, G.; Lo Monte, A.I. Anesthesia protocols in laboratory animals used for scientific purposes. Acta Biomed. Atenei Parm. 2018, 89, 337–342. [Google Scholar] [CrossRef]
- Flecknell, P. Rodent analgesia: Assessment and therapeutics. Vet. J. 2018, 232, 70–77. [Google Scholar] [CrossRef] [PubMed]
- Miller, A.L.; Richardson, C.A. Rodent Analgesia. Vet. Clin. N. Am. Exot. Anim. Pract. 2011, 14, 81–92. [Google Scholar] [CrossRef]
- Mckay, L. The peri/postoperative analgesic effect of intravenous paracetamol in dogs. Vet. Evid. 2024, 9, 1–9. [Google Scholar]
- Bradbury, A.G.; Eddleston, M.; Clutton, R.E. Pain management in pigs undergoing experimental surgery; a literature review (2012–4). Br. J. Anaesth. 2016, 116, 37–45. [Google Scholar] [PubMed]
- Simon, F.; Giudici, R.; Scheuerle, A.; Gröger, M.; Asfar, P.; Vogt, J.A.; Wachter, U.; Ploner, F.; Georgieff, M.; Möller, P.; et al. Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: A randomized controlled trial. Crit. Care 2009, 13, R113. [Google Scholar] [CrossRef] [PubMed]
- Ji, M.H.; Yang, J.J.; Wu, J.; Li, R.Q.; Li, G.M.; Fan, Y.X.; Li, W.-Y. Experimental sepsis in pigs—Effects of vasopressin on renal, hepatic, and intestinal dysfunction. Upsala J. Med. Sci. 2012, 117, 257–263. [Google Scholar] [CrossRef] [PubMed]
- Langenberg, C.; Wan, L.; Egi, M.; May, C.N.; Bellomo, R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006, 69, 1996–2002. [Google Scholar] [CrossRef] [PubMed]
- Chvojka, J.; Sykora, R.; Krouzecky, A.; Radej, J.; Varnerova, V.; Karvunidis, T.; Hes, O.; Novak, I.; Radermacher, P.; Matejovic, M. Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs. Crit. Care 2008, 12, R164. [Google Scholar] [CrossRef] [PubMed]
- Woźnica, E.A.; Inglot, M.; Woźnica, R.K.; Łysenko, L. Liver dysfunction in sepsis. Adv. Clin. Exp. Med. 2018, 27, 547–552. [Google Scholar] [CrossRef] [PubMed]
- Lee, D.W. Catheter-based renal sympathetic denervation induces acute renal inflammation through activation of caspase-1 and NLRP3 inflammasome. Anatol. J. Cardiol. 2018, 21, 134–141. [Google Scholar] [CrossRef]
- Li, D.; Wang, Q.; Zhang, Y.; Li, D.; Yang, D.; Wei, S.; Su, L.; Ye, T.; Zheng, X.; Peng, K.; et al. A Novel Swine Model of Spontaneous Hypertension with Sympathetic Hyperactivity Responds Well to Renal Denervation. Am. J. Hypertens. 2016, 29, 63–72. [Google Scholar] [PubMed]
- Vakhrushev, A.D.; Condori Leandro, H.I.; Goncharova, N.S.; Korobchenko, L.E.; Mitrofanova, L.B.; Lebedev, D.S.; Mikhaylov, E.N. Extended Renal Artery Denervation Is Associated with Artery Wall Lesions and Acute Systemic and Pulmonary Hemodynamic Changes: A Sham-Controlled Experimental Study. Cardiovasc. Ther. 2020, 2020, 8859663. [Google Scholar] [CrossRef] [PubMed]
- Verloop, W.L.; Hubens, L.E.G.; Spiering, W.; Doevendans, P.A.; Goldschmeding, R.; Bleys, R.L.A.W.; Voskuil, M. The Effects of Renal Denervation on Renal Hemodynamics and Renal Vasculature in a Porcine Model. PLoS ONE 2015, 10, e0141609. [Google Scholar] [CrossRef] [PubMed]
- Tsioufis, C.; Papademetriou, V.; Dimitriadis, K.; Tsiachris, D.; Thomopoulos, C.; Park, E.; Hata, C.; Papalois, A.; Stefanadis, C. Catheter-based renal sympathetic denervation exerts acute and chronic effects on renal hemodynamics in swine. Int. J. Cardiol. 2013, 168, 987–992. [Google Scholar] [CrossRef] [PubMed]
- Vukadinović, D.; Lauder, L.; Kandzari, D.E.; Bhatt, D.L.; Kirtane, A.J.; Edelman, E.R.; Schmieder, R.E.; Azizi, M.; Böhm, M.; Mahfoud, F. Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis. Circulation 2024, 150, 1599–1611. [Google Scholar] [CrossRef] [PubMed]
- Bhattacharjee, A.; Datta, P.K.; Kumar, V.; Ravikumar, R.H.; Sathe, P.; Kundu, R. Timing of Vasopressin Initiation in Patients with Septic Shock: An Updated Systematic Review and Meta-analysis with Trial Sequential Analysis. Indian J. Crit. Care Med. 2025, 29, 839–850. [Google Scholar] [CrossRef] [PubMed]
- Garofalo, A.M.; Lorente-Ros, M.; Goncalvez, G.; Carriedo, D.; Ballén-Barragán, A.; Villar-Fernández, A.; Peñuelas, Ó.; Herrero, R.; Granados-Carreño, R.; Lorente, J.A. Histopathological changes of organ dysfunction in sepsis. Intensiv. Care Med. Exp. 2019, 7, 45. [Google Scholar] [CrossRef]
- Tenzi, J.; Hurtado, J.; Nin, N.; Rodriguez, F.; Molina, C.; Aunchayna, M. Renal histopathology in critically ill patients with Septic Acute Kidney Injury(S-AKI). J. Crit. Care 2022, 68, 38–41. [Google Scholar] [CrossRef] [PubMed]






| Characteristics | All (N = 14) | R Group (N = 9) | C Group (N = 5) | p Value |
|---|---|---|---|---|
| Sex (male/female) | 10/4 | 6/3 | 4/1 | 0.266 |
| Age (months) | 13.7 ± 1.7 | 13.6 ± 1.7 | 14 ± 2 | 0.671 |
| Weight (kg) | 26.5 ± 1.9 | 26.1 ± 1.9 | 27.2 ± 1.9 | 0.326 |
| SBP (mmHg) | 118.9 ± 8.8 | 120.2 ± 8.2 | 116.4 ± 10.3 | 0.343 |
| DBP (mmHg) | 65.2 ± 6.4 | 63 ± 6.3 | 69 ± 4.9 | 0.1 |
| HR (beats/min) | 90.9 ± 8.5 | 93 ± 7.7 | 87.4 ± 9.7 | 0.398 |
| URINE (mL) | 84.6 | 79.4 ± 8.5 | 94 ± 19.2 | 0.097 |
| WBC (N/μL) | 14,241 ± 2656 | 14,511 ± 3142 | 13,680 ± 1620 | 0.637 |
| CRP (mg/dL) | 0.078 ± 0.07 | 0.087 ± 0.085 | 0.06 ± 0.025 | 0.561 |
| PT (s) | 9.31 ± 2.33 | 9.03 ± 2.31 | 9.82 ± 2.53 | 0.886 |
| INR | 0.83 ± 0.2 | 0.8 ± 0.2 | 0.88 ± 0.23 | 0.884 |
| aPTT (s) | 21 ± 24.9 | 20.2 ± 26.8 | 22.3 ± 24 | 0.921 |
| PLT (N/μL) | 554,571 ± 245,886 | 547,000 ± 210,829 | 568,200 ± 327,467 | 0.86 |
| BUN (mg/dL) | 17 ± 5.7 | 15.2 ± 4.5 | 20.2 ± 6.8 | 0.271 |
| CREA (mg/dL) | 1.05 ± 0.25 | 1.07 ± 0.27 | 1 ± 0.22 | 0.762 |
| K (mEq/L) | 4 ± 0.62 | 3.8 ± 0.7 | 4.2 ± 0.36 | 0.278 |
| Na (mEq/L) | 135 ± 6.7 | 136 ± 6.8 | 132 ± 6.2 | 0.711 |
| SGOT (U/L) | 58.6 ± 30.7 | 56.5 ± 31.5 | 62.2 ± 32.5 | 0.834 |
| SGPT (U/L) | 63.2 ± 19.9 | 60 ± 19 | 68.4 ± 22.6 | 0.772 |
| Group | Alteration After Shock | 95% CI | p Value After Shock | 95% CI | p Value R vs. C | p Interaction BH | |
|---|---|---|---|---|---|---|---|
| SBP (mmHg) | R | −57.67 | (−65.12, −50.22) | <0.001 | (16.16, 32.33) | <0.001 | <0.001 |
| C | −29.6 | (−39.6, −19.6) | <0.001 | ||||
| DBP (mmHg) | R | −23.33 | (−29.73, −16.93) | <0.001 | (−2.26, 12.31) | 0.17 | <0.001 |
| C | −30.2 | (−32.79, −15.61) | <0.001 | ||||
| HR (beats/min) | R | +47.56 | (35.16, 59.95) | <0.01 | (−34.47, −8.41) | <0.01 | 0.0053 |
| C | +31.6 | (14.97. 48.23) | <0.01 | ||||
| URINE (mL) | R | −81.67 | (−94.54, −68.79) | <0.001 | (−14.72, 14.72) | 1 | 0.0107 |
| C | −94 | (−111.28, −76.72) | <0.001 | ||||
| WBC (N/μL) | R | +1463 | (−2007.11, 4933.78) | 0.647 | (−4377.43, 2708.54) | 0.636 | 0.549 |
| C | +1460 | (−3196.09, 6116.09) | 0.921 | ||||
| CRP (mg/dL) | R | +0.092 | (0.01, 0.17) | <0.01 | (−0.18, 0.01) | 0.079 | 0.3705 |
| C | +0.034 | (−0.07, 0.14) | 0.448 | ||||
| PT (s) | R | +51.13 | (40.05, 62.22) | <0.001 | (−35.23, −12.98) | <0.001 | 0.0096 |
| C | +26.24 | (11.37, 41.11) | <0.001 | ||||
| INR | R | +4.61 | (3.62, 5.6) | <0.001 | (−3.17, −1.17) | <0.001 | 0.0096 |
| C | +2.37 | (1.04, 3.7) | <0.001 | ||||
| aPTT (s) | R | +110.68 | (67.11, 154.24) | <0.001 | (−79.41, 8.03) | 0.107 | 0.324 |
| C | +72.86 | (14.41, 131.31) | 0.013 | ||||
| PLT (N/μL) | R | −427,444 | (−649,544.23, −205,344.66) | <0.001 | (−211,434.49, 278,323.38) | 0.783 | 0.2187 |
| C | −415,200 | (−713,178.12, −117,221.88) | <0.01 | ||||
| BUN (mg/dL) | R | +24.11 | (17.21, 31.01) | <0.001 | (−11.83, 6.36) | 0.543 | 0.2187 |
| C | +16.4 | (7.15, 25.65) | <0.001 | ||||
| CREA (mg/dL) | R | +0.993 | (0.61, 1.37) | <0.001 | (−1.06, −0.02) | 0.04 | 0.2171 |
| C | +0.532 | (0.02, 1.04) | 0.04 | ||||
| K (mEq/L) | R | +1.06 | (0.47, 1.64) | <0.001 | (−0.93, 0.53) | 0.581 | 0.2187 |
| C | +0.46 | (−0.32, 1.24) | 0.342 | ||||
| Na (mEq/L) | R | −11.89 | (−35.34, 11.56) | 0.474 | (−15.38, 31.69) | 0.487 | 0.4821 |
| C | +0.6 | (−30.86, 32.06) | 1 | ||||
| SGOT (U/L) | R | +23.78 | (−30.03, 77.59) | 0.602 | (−16.18, 92.71) | 0.163 | 0.4514 |
| C | +56.40 | (−15.79, 128.59) | 0.148 | ||||
| SGPT (U/L) | R | +33.33 | (−17.11, 83.78) | 0.254 | (−6.05, 106.71) | 0.078 | 0.324 |
| C | +75.60 | (7.93, 143.28) | 0.0267 |
| Tissue | Pathological Lesion | Groups | OR | 95% CI | p Value | p Interaction BH | |
|---|---|---|---|---|---|---|---|
| R | C | ||||||
| Kidney | Acute Tubular Injury | 78% | 80% | 0.920 | (0.024, 15.096) | 1 | 1 |
| Glomerular Damage | 33% | 80% | 0.157 | (0.004, 1.762) | 0.265 | 0.687 | |
| Interstitial Capillary Congestion | 100% | 100% | NC | NC | 1 | 1 | |
| Microhemorrhages | 78% | 60% | 2.176 | (0.162, 30.473) | 0.58 | 0.844 | |
| Lung | Alveolar Damage | 78% | 40% | 4.468 | (0.412, 66.083) | 0.265 | 0.687 |
| Edema | 33% | 40% | 0.761 | (0.069, 9.531) | 1 | 1 | |
| Leukocytic Infiltration | 78% | 20% | 10.368 | (0.871, 387.909) | 0.09 | 0.5 | |
| Capillary Congestion | 100% | 100% | NC | NC | 1 | 1 | |
| Atelectasis | 89% | 40% | 9.034 | (0.679, 348.734) | 0.094 | 0.5 | |
| Microhemorrhages | 56% | 20% | 4.185 | (0.375, 146.356) | 0.3 | 0.687 | |
| Heart | Edema—Interfibrillar Distance | 78% | 80% | 0.920 | (0.024, 15.096) | 1 | 1 |
| Capillary Congestion | 100% | 80% | NC | NC | 0.357 | 0.714 | |
| Microscopic Bleeding | 44% | 60% | 0.566 | (0.046, 5.636) | 1 | 1 | |
| Leukocytic Infiltration | 33% | 20% | 1.807 | (0.143, 65.053) | 1 | 1 | |
| Liver | Capillary Congestion | 78% | 100% | NC | NC | 0.5 | 0.844 |
| Degenerative Changes | 22% | 80% | 0.096 | (0.003, 1.148) | 0.09 | 0.5 | |
| Portal Tract Inflammation | 56% | 80% | 0.359 | (0.010, 4.143) | 0.58 | 0.844 | |
| Kupffer Cell Hyperplasia | 67% | 100% | NC | NC | 0.258 | 0.687 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Bratko, A.; Kamparoudis, A.; Doumas, M.; Ballas, K.; Arapoglou, S.; Tzortzi, I.; Savvas, I.; Marouda, C.; Psalla, D.; Zacharioudakis, G. Does Renal Sympathetic Denervation Impact the Outcome in Sepsis-Induced Shock? An Experimental Porcine Model. J. Clin. Med. 2026, 15, 4983. https://doi.org/10.3390/jcm15134983
Bratko A, Kamparoudis A, Doumas M, Ballas K, Arapoglou S, Tzortzi I, Savvas I, Marouda C, Psalla D, Zacharioudakis G. Does Renal Sympathetic Denervation Impact the Outcome in Sepsis-Induced Shock? An Experimental Porcine Model. Journal of Clinical Medicine. 2026; 15(13):4983. https://doi.org/10.3390/jcm15134983
Chicago/Turabian StyleBratko, Aikaterini, Apostolos Kamparoudis, Michael Doumas, Konstantinos Ballas, Stergios Arapoglou, Iliana Tzortzi, Ioannis Savvas, Christina Marouda, Dimitra Psalla, and Georgios Zacharioudakis. 2026. "Does Renal Sympathetic Denervation Impact the Outcome in Sepsis-Induced Shock? An Experimental Porcine Model" Journal of Clinical Medicine 15, no. 13: 4983. https://doi.org/10.3390/jcm15134983
APA StyleBratko, A., Kamparoudis, A., Doumas, M., Ballas, K., Arapoglou, S., Tzortzi, I., Savvas, I., Marouda, C., Psalla, D., & Zacharioudakis, G. (2026). Does Renal Sympathetic Denervation Impact the Outcome in Sepsis-Induced Shock? An Experimental Porcine Model. Journal of Clinical Medicine, 15(13), 4983. https://doi.org/10.3390/jcm15134983

